// App-Quantinova.ai

PB0439 : Efficacy and safety of apixaban versus warfarin in Morbid obese patients with venous thromboembolism.

Researchers

Presenter

  • H. Almajed

Principal Investigators

  • N/A

Medical Centers

  • King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

  • King Abdulaziz Medical City, Riyadh, Saudi Arabia

Locations

  • Saudi Arabia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Body mass index

Drug/Treatment

  • apixaban

  • Warfarin

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved